NasdaqCM - Nasdaq Real Time Price
USD
Profusa, Inc. (PFSA)
0.7201
-0.0508
(-6.59%)
As of 1:54:50 PM EDT. Market Open.
Key Executives
Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Dr. Chung-Bin Hwang Ph.D.
|
President | 2.3M | -- | 1968 |
|
Mr. Fred S. Knechtel
|
Chief Financial Officer | 851.6k | -- | 1961 |
|
Mr. Jack E. Stover CPA
|
CEO & Executive Chairman | -- | -- | 1953 |
|
Mr. William McMillan
|
Co-founder, Chief Scientific Officer & Head of Research | -- | -- | 1951 |
|
Mr. David Icke
|
Head of Digital Health Business | -- | -- | -- |
|
Mr. Sean Givens
|
Head of Government Business | -- | -- | -- |
Profusa, Inc.
- Sector:
- Healthcare
- Industry: Medical Devices
Description
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
Corporate Governance
Profusa, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
